BAKER Bros. Advisors L.P., Director, 10% Owner at AQUINOX PHARMACEUTICALS, INC (AQXP), bought 371,525 shares at $2.83 ($1.1M) on 2019-08-06, disclosed to the SEC on 2019-08-08.
Open-market purchase of $1.1M AQXP by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.83 | 9,445 | $27K | 2.4% |
| 2 | $2.83 | 855 | $2K | 0.2% |
| 3 | $2.85 | 5,932 | $17K | 1.5% |
| 4 | $2.85 | 65,568 | $187K | 16.7% |
| 5 | $2.96 | 5,869 | $17K | 1.6% |
| 6 | $2.96 | 531 |
| $2K |
| 0.1% |
| 7 | $3.02 | 209,382 | $633K | 56.8% |
| 8 | $3.02 | 18,943 | $57K | 5.1% |
| 9 | $3.15 | 50,436 | $159K | 14.3% |
| 10 | $3.15 | 4,564 | $14K | 1.3% |
| Total | $3.00 avg | 371,525 | $1.1M | 100% |
| Filing → |
| IGMS | BUY | 2024-03-28 | $6.8M | — | Filing → |
| MDGL | BUY | 2023-12-14 | $45.0M | — | Filing → |
| TRDA | BUY | 2022-05-24 | $396K | — | Filing → |